SCHEMBL4553615

SCHEMBL4553615

NC(=O)c1c(O)c2cc(Cl)cnc2n(Cc2ccc(C(F)(F)F)nc2)c1=O

nearest known ligand 0.75

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGLN1 Q9GZT9 4/20 0.75
EGLN2 Q96KS0 3/20 0.43
EGLN3 Q9H6Z9 3/20 0.43
CNR2 P34972 4/20 0.42
HSD17B13 Q7Z5P4 1/20 0.42
LMNA P02545 1/20 0.39
XBP1 P17861 1/20 0.39
NR3C1 P04150 1/20 0.38
LCK P06239 1/20 0.38
PGR P06401 1/20 0.38
CSF1R P07333 1/20 0.38
CHRM2 P08172 1/20 0.38
HTR1A P08908 1/20 0.38
ADRA2A P08913 1/20 0.38
PDGFRB P09619 1/20 0.38
ADORA3 P0DMS8 1/20 0.38
KIT P10721 1/20 0.38
CHRM1 P11229 1/20 0.38
PDGFRA P16234 1/20 0.38
FLT1 P17948 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4553613 0.91 EGLN1 (0.76) EGLN1EGLN2EGLN3CNR2HSD17B13
SCHEMBL13437410 0.86 EGLN1 (0.69) EGLN1EGLN2EGLN3CNR2HSD17B13
SCHEMBL3512354 0.86 EGLN1 (1.00) EGLN1EGLN2EGLN3CNR2
SCHEMBL13437414 0.82 EGLN1 (0.81) EGLN1EGLN2EGLN3CNR2HSD17B13
SCHEMBL7833529 0.75 EGLN1 (0.56) EGLN1CNR2CNR1L3MBTL1
SCHEMBL3518609 0.72 EGLN1 (0.52) EGLN1EGLN2EGLN3CNR2HSD17B13
SCHEMBL7833351 0.72 EGLN1 (0.54) EGLN1CNR2LMNAL3MBTL1
SCHEMBL3513806 0.71 EGLN1 (0.51) EGLN1EGLN2EGLN3CNR2LMNA
SCHEMBL3514759 0.70 EGLN1 (0.75) EGLN1EGLN2EGLN3CNR2CNR1
SCHEMBL4553700 0.69 EGLN1 (0.49) EGLN1EGLN2EGLN3CNR2HSD17B13

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2136810-A1 NOVEL 1,8-NAPHTHYRIDINE COMPOUNDS Merck & Co., Inc. (US) 2009-12-30 EP disclosed
WO-2008130527-A1 NOVEL 1,8-NAPHTHYRIDINE COMPOUNDS MERCK & CO., INC. (US) 2008-10-30 WO disclosed